Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,322,209
+$274,760 QoQ
Shares Held
28,831
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#1,308
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2021CallValue
$32,870,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $104,911,681 across 12 Drug Manufacturers - General names. JNJ ranks #8 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
|
96,626 | $20,877,013 | |
| 2 | AZN |
Astrazeneca PLC
|
62,530 | $11,856,938 | |
| 3 | SNY |
Sanofi
|
269,515 | $11,497,509 | |
| 4 | LLY |
ELI LILLY & Co
|
8,040 | $9,643,418 | |
| 5 | NVS |
Novartis AG
|
50,000 | $7,836,000 | |
| 6 | ABBV |
AbbVie Inc.
|
30,256 | $7,613,619 | |
| 7 | MRK |
Merck & Co., Inc.
|
58,600 | $7,530,100 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
28,831 | $7,322,209 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,322,209 | 28,831 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,047,449 | 28,831 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,415,225 | 35,831 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,570,884 | 40,831 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,236,935 | 40,831 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,761,493 | 52,831 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,098,959 | 69,831 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,316,811 | 69,831 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,206,498 | 69,831 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,628,465 | 79,831 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,512,710 | 79,831 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $14,769,928 | 94,831 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,834,427 | 119,831 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,573,805 | 119,831 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $19,401,646 | 109,831 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $35,310,427 | 216,151 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $49,072,817 | 276,451 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $52,286,926 | 295,023 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $26,536,891 | 155,123 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $38,590,102 | 238,948 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $66,819,861 | 405,608 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $32,870,000 | 200,000 | Call | Defined | 2021-05-17 | |
| 2021-03-31 | $74,598,465 | 453,900 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $53,225,916 | 338,200 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $56,574,400 | 380,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $42,189,000 | 300,000 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $45,718,867 | 348,653 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||